Literature DB >> 20414986

Accelerate medical breakthroughs by ending disease earmarks.

Sharon F Terry1.   

Abstract

Mesh：

Year:  2010        PMID： 20414986     DOI： 10.1038/nrg2782

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN： 1471-0056            Impact factor:   53.242


× No keyword cloud information.
  4 in total

Review 1.  Inflammation and cancer: back to Virchow?

Authors:  F Balkwill; A Mantovani
Journal:  Lancet       Date:  2001-02-17       Impact factor: 79.321

2.  Use of canakinumab in the cryopyrin-associated periodic syndrome.

Authors:  Helen J Lachmann; Isabelle Kone-Paut; Jasmin B Kuemmerle-Deschner; Kieron S Leslie; Eric Hachulla; Pierre Quartier; Xavier Gitton; Albert Widmer; Neha Patel; Philip N Hawkins
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

Review 3.  Rilonacept in the treatment of chronic inflammatory disorders.

Authors:  Michael F McDermott
Journal:  Drugs Today (Barc)       Date:  2009-06       Impact factor: 2.245

Review 4.  Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan?

Authors:  Peter Matt; Jennifer Habashi; Thierry Carrel; Duke E Cameron; Jennifer E Van Eyk; Harry C Dietz
Journal:  J Thorac Cardiovasc Surg       Date:  2008-02       Impact factor: 5.209
  4 in total
  1 in total

1.  Disease advocacy organizations catalyze translational research.

Authors:  Sharon F Terry
Journal:  Front Genet       Date:  2013-06-04       Impact factor: 4.599
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.